
aspirin
acetylsalicylic acid







clinical data


pronunciation
acetylsalicylic acid əˌsiːtəlˌsælɪˈsɪlɪk


synonyms
2acetoxybenzoic acid
acetylsalicylate
acetylsalicylic acid
oacetylsalicylic acid aspirin aspirin usan


ahfsdrugscom
monograph


medlineplus
a682878


license data



aspirin





pregnancy
category




risk ruled trimester








routes
administration
mouth rectal lysine acetylsalicylate given intravenously intramuscularly


code



a01ad05 b01ac06 n02ba01





legal status


legal status



pharmacy except given intravenously case schedule used animal medicine schedule dose higher usual
general sales list






pharmacokinetic data


bioavailability
80–1002


protein binding
80–901


metabolism
liver cyp2c19 possibly cyp3a also hydrolysed salicylate wall1


biological halflife
dosedependent doses large doses1


excretion
urine 80–100 sweat saliva feces2


identifiers




iupac name

2acetoxybenzoic acid





number



50782





pubchem



2244





iupharbps



4139





drugbank



db00945





chemspider



2157





unii



r16co5y76e





kegg



d00109





chebi



chebi15365





chembl



chembl25





ligand



pdbe rcsb





echa infocard
100000059


chemical physical data


formula
c9h8o4


molar mass
180157 gmol


model jsmol



interactive image





density
gcm3


melting point



boiling point
decomposes


solubility water
mgml




smiles


occoc1ccccc1coo








inchi


inchi1sc9h8o4c161013853247891112h25h1h3h1112


keybsynrymutxbxsquhfffaoysan






verify


aspirin also known acetylsalicylic acid medication used treat pain fever inflammation3 specific inflammatory conditions aspirin used include kawasaki disease pericarditis rheumatic fever3 aspirin given shortly heart attack decreases risk death3 aspirin also used longterm help prevent heart attacks ischaemic strokes blood clots people high risk3 aspirin also decrease risk certain types cancer particularly colorectal cancer4 pain fever effects typically begin within minutes3 aspirin nonsteroidal antiinflammatory drug nsaid works similar nsaids also suppresses normal functioning platelets3
common side effects include upset stomach3 significant side effects include stomach ulcers stomach bleeding worsening asthma3 bleeding risk greater among older drink alcohol take nsaids blood thinners3 aspirin recommended last part pregnancy3 generally recommended children infections risk reyes syndrome3 high doses result ringing ears3
precursor aspirin form leaves willow tree used health effects least 2400 years56 1853 chemist charles frédéric gerhardt treated sodium salicylate acetyl chloride produce acetylsalicylic acid first time7 second half nineteenth century chemists established chemical structure came efficient methods make it769–75 1897 scientists bayer began studying acetylsalicylic acid lessirritating replacement common salicylate medicines769–75 1899 bayer named drug aspirin selling around world8 word aspirin bayers brand name however rights trademark lost sold many countries9 aspirins popularity grew first half twentieth century leading competition many brands formulations9
aspirin widely used medications globally estimated 40000 tonnes billion pills consumed year510 world health organizations list essential medicines effective safe medicines needed health system11 aspirin available generic medication wholesale cost developing world 2014 0002 0025 dose12 2015 cost typical month medication united states less us2513



contents


medical

pain

headache


fever
inflammation
heart attacks strokes

high risk
lower risk
surgery


cancer prevention
uses
resistance
dosage


adverse effects

contraindications
gastrointestinal
central effects
reyes syndrome
skin
adverse effects
overdose
interactions


chemical properties

synthesis


physical properties

polymorphism


mechanism action

discovery mechanism
prostaglandins thromboxanes
cox1 cox2 inhibition
additional mechanisms


pharmacokinetics
history

trademark
compendial status


veterinary medicine
references
external links



medical useedit
aspirin used treatment number conditions including fever pain rheumatic fever inflammatory diseases rheumatoid arthritis pericarditis kawasaki disease14 lower doses aspirin also shown reduce risk death heart attack risk stroke circumstances151617 evidence aspirin effective preventing colorectal cancer though mechanisms effect unclear18 united states dose aspirin deemed reasonable years risk cardiovascular disease increased risk bleeding otherwise healthy19
painedit




aspirin grains pain






uncoated aspirin tablets consisting acetylsalicylic acid along minor amount inert fillers binders


aspirin effective analgesic acute pain generally considered inferior ibuprofen alleviation pain aspirin likely cause gastrointestinal bleeding20 aspirin generally ineffective pains caused muscle cramps bloating gastric distension acute skin irritation21 nsaids combinations aspirin caffeine provide slightly greater pain relief aspirin alone22 effervescent formulations aspirin alkaseltzer blowfish23 relieve pain faster aspirin tablets24 makes useful treatment migraines25 topical aspirin effective treating types neuropathic pain26
headacheedit
aspirin either combined formulation effectively treats certain types headache efficacy questionable others secondary headaches meaning caused another disorder trauma promptly treated medical provider
among primary headaches international classification headache disorders distinguishes tension headache common migraine cluster headache aspirin overthecounter analgesics widely recognized effective treatment tension headache27
aspirin especially component aspirinparacetamolcaffeine combination considered firstline therapy treatment migraine comparable lower doses sumatriptan effective stopping migraines first beginning28
feveredit
like ability control pain aspirins ability control fever action prostaglandin system irreversible inhibition cox29 although aspirins antipyretic adults well established many medical societies regulatory agencies including american academy family physicians american academy pediatrics food drug administration strongly advise using aspirin treatment fever children risk reyes syndrome rare often fatal illness associated aspirin salicylates children episodes viral bacterial infection303132 risk reyes syndrome children 1986 required labeling aspirincontaining medications advising children teenagers33
inflammationedit
aspirin used antiinflammatory agent acute longterm inflammation34 well treatment inflammatory diseases rheumatoid arthritis14
heart attacks strokesedit
aspirin important part treatment myocardial infarction heart attack35 trial found among likely stsegment elevation aspirin saves life reducing 30day death rate 9436 difference major bleeding small increase minor bleeding amounting roughly every people given aspirin36
high riskedit
people already heart attack stroke taking aspirin daily years prevented cardiovascular problem heart attack stroke death also caused nonfatal bleeding problems occur people373839
lower riskedit
previous history heart disease aspirin decreases risk nonfatal myocardial infarction change overall risk death40 study found among never heart attack stroke taking aspirin daily year prevents 1667 nonfatal heart attack stroke caused 3333 nonfatal bleeding event however study population relatively higher risk never heart attack stroke41
aspirin appears offer little benefit lower risk heart attack stroke—for instance without history events preexisting disease studies recommend aspirin casebycase basis4243 others suggested risks events gastrointestinal bleeding enough outweigh potential benefit recommended using aspirin primary prevention entirely44 aspirin also suggested component polypill prevention cardiovascular disease4546
complicating aspirin prevention phenomenon aspirin resistance4748 people resistant aspirins efficacy reduced49 authors suggested testing regimens identify people resistant aspirin50
surgeryedit
percutaneous coronary interventions pcis placement coronary artery stent agency healthcare research quality guideline recommends aspirin taken indefinitely51 frequently aspirin combined receptor inhibitor clopidogrel prasugrel ticagrelor prevent blood clots called dual antiplatelet therapy dapt united states european union guidelines disagree somewhat long indications combined therapy continued surgery guidelines recommend dapt least months guidelines recommend dapt 6–12 months drugeluting stent placement52 however agree aspirin continued indefinitely dapt complete
cancer preventionedit
aspirin thought reduce overall risk getting cancer dying cancer53 effect particularly beneficial colorectal cancer crc18545556 must taken least 1020 years benefit57 also slightly reduce risk endometrial cancer58 breast cancer prostate cancer59
conclude benefits greater risks bleeding average risk53 others unclear benefits greater risk6061 given uncertainty 2007 united states preventive services task force guidelines topic recommended aspirin prevention people average risk62 nine years later however uspstf issued grade recommendation lowdose aspirin mgday “for primary prevention adults years greater 10year risk increased risk bleeding life expectancy least years willing take lowdose aspirin daily least years”63
usesedit
aspirin firstline treatment fever jointpain symptoms acute rheumatic fever therapy often lasts weeks rarely indicated longer periods fever pain subsided aspirin longer necessary since decrease incidence heart complications residual rheumatic heart disease6465 naproxen shown effective aspirin less toxic limited clinical experience naproxen recommended secondline treatment6466
along rheumatic fever kawasaki disease remains indications aspirin children67 spite lack high quality evidence effectiveness68
lowdose aspirin supplementation moderate benefits used prevention preeclampsia6970 benefit greater started early pregnancy71
resistanceedit
people aspirin strong effect platelets others effect known aspirinresistance insensitivity study suggested women likely resistant men72 different aggregate study 2930 people found resistant73 study italian people though found apparent aspirinresistant subjects truly resistant others noncompliant74 another study healthy volunteers found subjects truly resistant pseudoresistance reflecting delayed reduced drug absorption75verification needed
dosageedit




coated 5grain aspirin tablets






5grain aspirin usage guidance label bottle aspirin indicates dosage


adult aspirin tablets produced standardised sizes vary slightly country country example britain grains united states smaller doses based standards tablets 1​1⁄4grain tablets commonly called baby aspirin babystrength originally—but longer—intended administered infants children76 medical significance occurs slight difference dosage tablets
general adults doses taken four times fever arthritis77 doses near maximal daily dose used historically treatment rheumatic fever78 prevention myocardial infarction someone documented suspected coronary artery disease much lower doses taken daily77
march 2009 recommendations uspstf aspirin primary prevention coronary heart disease encourage aged 45–79 women aged 55–79 aspirin potential benefit reduction stroke women outweighs potential harm increase gastrointestinal hemorrhage79 study said regular dose aspirin female users lower risk death cardiovascular disease lower risk death cause79 lowdose aspirin also associated trend toward lower risk cardiovascular events lower aspirin doses mgday optimize efficacy safety people requiring aspirin longterm prevention79
children kawasaki disease aspirin taken dosages based body weight initially four times weeks lower dose daily eight weeks80
adverse effectsedit
contraindicationsedit
aspirin taken people allergic ibuprofen naproxen8182 salicylate intolerance8384 generalized drug intolerance nsaids caution exercised asthma nsaidprecipitated bronchospasm owing effect stomach lining manufacturers recommend people peptic ulcers mild diabetes gastritis seek medical advice using aspirin8185 even none conditions present risk stomach bleeding still increased aspirin taken alcohol warfarin8182 people hemophilia bleeding tendencies take aspirin salicylates8185 aspirin known cause hemolytic anemia people genetic disease glucose6phosphate dehydrogenase deficiency particularly large doses depending severity disease86 aspirin dengue fever recommended owing increased bleeding tendency87 people kidney disease hyperuricemia gout take aspirin inhibits kidneys ability excrete uric acid thus exacerbate conditions aspirin given children adolescents control cold influenza symptoms linked reyes syndrome88
gastrointestinaledit
aspirin shown increase risk gastrointestinal bleeding89 although entericcoated formulations aspirin advertised gentle stomach study enteric coating seem reduce risk89 combining aspirin nsaids also shown increase risk89 using aspirin combination clopidogrel warfarin also increases risk upper gastrointestinal bleeding90
blockade cox1 aspirin apparently results upregulation cox2 part gastric defense91 taking cox2 inhibitors concurrently aspirin increases gastric mucosal erosion92 therefore caution exercised combining aspirin natural supplements cox2inhibiting properties garlic extracts curcumin bilberry pine bark ginkgo fish resveratrol genistein quercetin resorcinol others
addition enteric coating buffering main method companies used mitigate problem gastrointestinal bleeding buffering agents intended work preventing aspirin concentrating walls stomach although benefits buffered aspirin disputed almost buffering agent used antacids used bufferin example uses magnesium oxide preparations calcium carbonate93
taking vitamin recently investigated method protecting stomach lining taking equal doses vitamin aspirin decrease amount stomach damage occurs compared taking aspirin alone9495
central effectsedit
large doses salicylate metabolite aspirin cause temporary tinnitus ringing ears based experiments rats action arachidonic acid nmda receptors cascade96
reyes syndromeedit
main article reyes syndrome
reyes syndrome rare severe illness characterized acute encephalopathy fatty liver occur children adolescents given aspirin fever illness infection 1981 1997 1207 cases reyes syndrome people younger reported centers disease control prevention reported three weeks preceding onset reyes syndrome commonly respiratory infection chickenpox diarrhea salicylates detectable children test results reported97 association reyes syndrome aspirin reported safety measures prevent including surgeon generals warning changes labeling aspirincontaining drugs implemented aspirin taken children declined considerably united states number reported cases reyes syndrome similar decline found united kingdom warnings pediatric aspirin issued97 food drug administration recommends aspirin aspirincontaining products given anyone fever88 british medicines healthcare products regulatory agency recommends children years take aspirin unless advice doctor98
skinedit
small number people taking aspirin result symptoms resembling allergic reaction including hives swelling headache reaction caused salicylate intolerance true allergy rather inability metabolize even small amounts aspirin resulting overdose
aspirin nsaids ibuprofen delay healing skin wounds99 aspirin however help heal venous ulcers healed following usual treatment100
adverse effectsedit
aspirin induce swelling skin tissues people study angioedema appeared hours ingesting aspirin people however aspirin taken alone cause angioedema people aspirin taken combination another nsaidinduced drug angioedema appeared101
aspirin causes increased risk cerebral microbleeds appearance scans smaller hypointense dark holes patches102103 cerebral microbleeds important since often occur prior ischemic stroke intracerebral hemorrhage binswanger disease alzheimers diseaseoriginal research
study group mean dosage aspirin estimated average absolute risk increase intracerebral hemorrhage events 10000 persons104 comparison estimated absolute risk reduction myocardial infarction events 10000 persons reduction events 10000 persons ischemic stroke104 cases already occurred aspirin results higher mortality dose resulting relative risk death within three months around confidence interval 46105
aspirin nsaids cause abnormally high blood levels potassium inducing hyporeninemic hypoaldosteronic state inhibition prostaglandin synthesis however agents typically cause hyperkalemia setting normal renal function euvolemic state106
aspirin cause prolonged bleeding operations days study 6499 people elective surgery required reoperations control bleeding twenty diffuse bleeding bleeding site diffuse discrete bleeding associated preoperative aspirin alone combination nsaids diffuse bleeding people107
july 2015 toughened warnings increased heart attack stroke risk associated nonsteroidal antiinflammatory drugs nsaid aspirin nsaid affected warnings108
overdoseedit
main article aspirin poisoning
aspirin overdose acute chronic acute poisoning single large dose taken chronic poisoning higher normal doses taken period time acute overdose mortality rate chronic overdose commonly lethal mortality rate 25109 chronic overdose especially severe children110 toxicity managed number potential treatments including activated charcoal intravenous dextrose normal saline sodium bicarbonate dialysis111 diagnosis poisoning usually involves measurement plasma salicylate active metabolite aspirin automated spectrophotometric methods plasma salicylate levels general range 30–100 usual therapeutic doses 50–300 people taking high doses 700–1400 following acute overdose salicylate also produced result exposure bismuth subsalicylate methyl salicylate sodium salicylate112113
interactionsedit
aspirin known interact drugs example acetazolamide ammonium chloride known enhance intoxicating effect salicylates alcohol also increases gastrointestinal bleeding associated types drugs8182 aspirin known displace number drugs proteinbinding sites blood including antidiabetic drugs tolbutamide chlorpropamide warfarin methotrexate phenytoin probenecid valproic acid well interfering beta oxidation important part valproate metabolism nsaids corticosteroids also reduce concentration aspirin ibuprofen negate antiplatelet effect aspirin used cardioprotection stroke prevention114 pharmacological activity spironolactone reduced taking aspirin known compete penicillin renal tubular secretion115 aspirin also inhibit absorption vitamin c116117unreliable medical source118
chemical propertiesedit
aspirin decomposes rapidly solutions ammonium acetate acetates carbonates citrates hydroxides alkali metals stable gradually hydrolyses contact moisture acetic salicylic acids solution alkalis hydrolysis proceeds rapidly clear solutions formed consist entirely acetate salicylate119
like flour mills factories make aspirin tablets must attention much powder gets inside building powderair mixture explosive national institute occupational safety health niosh recommended exposure limit united states mgm3 timeweighted average120 1989 occupational safety health administration osha legal permissible exposure limit aspirin mgm3 vacated aflcio osha decision 1993121
synthesisedit
synthesis aspirin classified esterification reaction salicylic acid treated acetic anhydride acid derivative causing chemical reaction turns salicylic acids hydroxyl group ester group rococh3 process yields aspirin acetic acid considered byproduct reaction small amounts sulfuric acid occasionally phosphoric acid almost always used catalyst method commonly employed undergraduate teaching labs122




reaction mechanism


formulations containing high concentrations aspirin often smell like vinegar123 aspirin decompose hydrolysis moist conditions yielding salicylic acetic acids124
physical propertiesedit
aspirin acetyl derivative salicylic acid white crystalline weakly acidic substance melting point boiling point °f125 acid dissociation constant °f126
polymorphismedit
polymorphism ability substance form crystal structure important development pharmaceutical ingredients many drugs receiving regulatory approval single crystal form polymorph long time crystal structure aspirin known aspirin might second crystalline form suspected since 1960s elusive second polymorph first discovered vishweshwar coworkers 2005127 fine structural details given bond al128 crystal type found attempted cocrystallization aspirin levetiracetam acetonitrile form stable reverts form ambient temperature unambiguous form salicylic molecules form centrosymmetric dimers acetyl groups acidic methyl proton carbonyl hydrogen bonds newly claimed form salicylic molecule forms hydrogen bonds neighboring molecules instead respect hydrogen bonds formed carboxylic acid groups polymorphs form identical dimer structurescitation needed
mechanism actionedit
main article mechanism action aspirin
discovery mechanismedit
1971 british pharmacologist john robert vane employed royal college surgeons london showed aspirin suppressed production prostaglandins thromboxanes129130 discovery awarded 1982 nobel prize physiology medicine jointly sune bergström bengt ingemar samuelsson131
prostaglandins thromboxanesedit
aspirins ability suppress production prostaglandins thromboxanes irreversible inactivation cyclooxygenase officially known prostaglandinendoperoxide synthase ptgs enzyme required prostaglandin thromboxane synthesis aspirin acts acetylating agent acetyl group covalently attached serine residue active site ptgs enzyme suicide inhibition makes aspirin different nsaids diclofenac ibuprofen reversible inhibitors
lowdose aspirin irreversibly blocks formation thromboxane platelets producing inhibitory effect platelet aggregation lifetime affected platelet days antithrombotic property makes aspirin useful reducing incidence heart attacks people heart attack unstable angina ischemic stroke transient ischemic attack132 aspirin able inhibit large proportion maximum thromboxane release provoked acutely prostaglandin synthesis little affected however higher doses aspirin required attain inhibition133
prostaglandins local hormones produced body diverse effects including transmission pain information brain modulation hypothalamic thermostat inflammation thromboxanes responsible aggregation platelets form blood clots heart attacks caused primarily blood clots doses aspirin seen effective medical intervention acute myocardial infarction
cox1 cox2 inhibitionedit
least different types cyclooxygenases cox1 cox2 acted aspirin aspirin irreversibly inhibits cox1 modifies enzymatic activity cox2 cox2 normally produces prostanoids proinflammatory aspirinmodified ptgs2 produces lipoxins antiinflammatory134verification needed newer nsaid drugs cox2 inhibitors coxibs developed inhibit ptgs2 intent reduce incidence gastrointestinal side effects10
however several cox2 inhibitors rofecoxib vioxx withdrawn last decade evidence emerged ptgs2 inhibitors increase risk heart attack stroke135136 endothelial cells lining microvasculature body proposed express ptgs2 selectively inhibiting ptgs2 prostaglandin production specifically pgi2 prostacyclin downregulated respect thromboxane levels ptgs1 platelets unaffected thus protective anticoagulative effect pgi2 removed increasing risk thrombus associated heart attacks circulatory problems since platelets unable synthesize ptgs aspirin irreversibly inhibited enzyme important difference reversible inhibitors
furthermore aspirin inhibiting ability cox2 form proinflammatory products prostaglandins converts enzymes activity prostaglandinforming cyclooxygenase lipoxygenaselike enzyme aspirintreated cox2 metabolizes variety polyunsaturated fatty acids hydroperoxy products metabolized specialized proresolving mediators aspirintriggered lipoxins aspirintriggered resolvins aspirintriggered maresins mediators possess potent antiinflammatory activity proposed aspirintriggered transition cox2 cyclooxygenase lipoxygenase activity consequential formation specialized proresolving mediators contributes antiinflammatory effects aspirin137138139
additional mechanismsedit
aspirin shown least three additional modes action uncouples oxidative phosphorylation cartilaginous hepatic mitochondria diffusing inner membrane space proton carrier back mitochondrial matrix ionizes release protons140 aspirin buffers transports protons high doses given actually cause fever owing heat released electron transport chain opposed antipyretic action aspirin seen lower doses addition aspirin induces formation noradicals body shown mice independent mechanism reducing inflammation reduced leukocyte adhesion important step immune response infection however evidence insufficient show aspirin helps fight infection141 recent data also suggest salicylic acid derivatives modulate signaling nfκb142 nfκb transcription factor complex plays central role many biological processes including inflammation
aspirin readily broken body salicylic acid antiinflammatory antipyretic analgesic effects 2012 salicylic acid found activate ampactivated protein kinase suggested possible explanation effects salicylic acid aspirin143144 acetyl portion aspirin molecule targets acetylation cellular proteins wellestablished phenomenon regulation protein function posttranslational level aspirin able acetylate several targets addition isoenzymes145146 acetylation reactions explain many hitherto unexplained effects aspirin
pharmacokineticsedit
acetylsalicylic acid weak acid little ionized stomach oral administration acetylsalicylic acid quickly absorbed cell membrane acidic conditions stomach increased larger surface area small intestine causes aspirin absorbed slowly ionised owing formation concretions aspirin absorbed much slowly overdose plasma concentrations continue rise hours ingestion147148149
50–80 salicylate blood bound albumin protein rest remains active ionized state protein binding concentrationdependent saturation binding sites leads free salicylate increased toxicity volume distribution 01–02 acidosis increases volume distribution enhancement tissue penetration salicylates149
much therapeutic doses salicylic acid metabolized liver conjugation glycine forms salicyluric acid glucuronic acid form different glucuronide esters conjugate acetyl group intact referred acyl glucuronide deacetylated conjugate phenolic glucuronide metabolic pathways limited capacity small amounts salicylic acid also hydroxylated gentisic acid large salicylate doses kinetics switch firstorder zeroorder metabolic pathways become saturated renal excretion becomes increasingly important149
salicylates excreted mainly kidneys salicyluric acid free salicylic acid salicylic phenol acyl glucuronides gentisic acid 23dihydroxybenzoic acid150 small doses less adult ingested pathways proceed firstorder kinetics elimination halflife h151152 higher doses salicylate ingested halflife becomes much longer h153 biotransformation pathways concerned formation salicyluric acid salicyl phenolic glucuronide become saturated154 renal excretion salicylic acid becomes increasingly important metabolic pathways become saturated extremely sensitive changes urinary 20fold increase renal clearance occurs urine increased urinary alkalinization exploits particular aspect salicylate elimination155
historyedit
main article history aspirin




1923 advertisement


medicines made willow salicylaterich plants appear clay tablets ancient sumer well ebers papyrus ancient egypt78–139 hippocrates referred salicylic reduce fevers around part pharmacopoeia western medicine classical antiquity middle ages9 willow bark extract became recognized specific effects fever pain inflammation mideighteenth century156 nineteenth century pharmacists experimenting prescribing variety chemicals related salicylic acid active component willow extract746–55
1853 chemist charles frédéric gerhardt treated acetyl chloride sodium salicylate produce acetylsalicylic acid first time746–48 second half nineteenth century academic chemists established compounds chemical structure devised efficient methods synthesis 1897 scientists drug firm bayer began investigating acetylsalicylic acid lessirritating replacement standard common salicylate medicines identified synthesize it769–75 1899 bayer dubbed drug aspirin selling around world827 word aspirin bayers brand name rather generic name drug however bayers rights trademark lost sold many countries aspirins popularity grew first half twentieth century leading fierce competition proliferation aspirin brands products9
aspirins popularity declined development acetaminophenparacetamol 1956 ibuprofen 1962 1960s 1970s john vane others discovered basic mechanism aspirins effects7226–231 clinical trials studies 1960s 1980s established aspirins efficacy anticlotting agent reduces risk clotting diseases7247–257 initial large studies lowdose aspirin prevent heart attacks published 1970s 1980s helped spur reform clinical research ethics guidelines human subject research federal often cited examples clinical trials included people drew general conclusions hold true women157158159
aspirin sales revived considerably last decades twentieth century remain strong twentyfirst widespread preventive treatment heart attacks strokes7267–269
trademarkedit
allowing aspirin years manufacturing chemists despite trademarkinfringing nature failure name product began selling direct bayer lost trademark united states 1918 affirmed court appeal 1921160 today aspirin generic word australia france india ireland zealand pakistan jamaica colombia philippines south africa ghana united kingdom united states161 aspirin capital remains registered trademark bayer germany canada mexico countries trademark owned bayer using acetylsalicylic acid markets using different packaging physical aspects each162163
compendial statusedit

united states pharmacopeia164
british pharmacopoeia165

veterinary medicineedit
aspirin sometimes used pain relief anticoagulant veterinary medicine primarily dogs sometimes horses although newer medications fewer side effects generally used instead
dogs horses susceptible gastrointestinal side effects associated salicylates convenient treatment arthritis older dogs shown promise cases laminitis horsescitation needed166 longer commonly used cases laminitis could counterproductive treatment aspirin used animals direct supervision veterinarian particular cats lack glucuronide conjugates excretion aspirin making potentially toxic167 clinical signs toxicosis occurred cats given mgkg aspirin every hours weeks168 dose recommended cats relief pain fever mgkg every hours169
referencesedit



brayfield january 2014 aspirin martindale complete drug reference pharmaceutical press retrieved april 2014
zorprin bayer buffered aspirin aspirin dosing indications interactions adverse effects medscape reference webmd archived original april 2014 retrieved april 2014
aspirin drugscom american society healthsystem pharmacists june 2016 archived original april 2017 retrieved august 2016
patrignani patrono august 2016 aspirin cancer journal american college cardiology 967–76 doi101016jjacc201605083 pmid 27561771
jones alan 2015 chemistry introduction medical health sciences john wiley sons isbn 9780470092903
ravina enrique 2011 evolution drug discovery traditional medicines modern drugs john wiley sons isbn 9783527326693
jeffreys diarmuid 2008 aspirin remarkable story wonder drug bloomsbury publishing isbn 9781596918160 archived original september 2017 46–48
mann charles plummer mark 1991 aspirin wars money medicine years rampant competition york knopf isbn 0394578945
aspirin chemical engineering news retrieved 20070813
warner warner mitchell 2002 cyclooxygenase3 cox3 filling gaps toward continuum proceedings national academy sciences united states america 13371–3 bibcode2002pnas9913371w doi101073pnas222543099 129677 pmid 12374850
model list essential medicines 19th list world health organization april 2015 archived original december 2016 retrieved december 2016
acetylsalicylic acid international drug price indicator guide retrieved august 2016
hamilton richart 2015 tarascon pocket pharmacopoeia 2015 deluxe labcoat jones bartlett learning isbn 9781284057560
aspirin american society healthsystem pharmacists archived original january 2011 retrieved april 2011
aspirin reducing risk heart attack stroke know facts food drug administration archived original august 2012 retrieved july 2012
aspirin prevention cardiovascular disease preventive services task force archived original july 2012 retrieved july 2012
seshasai wijesuriya sivakumaran nethercott erqou sattar february 2012 effect aspirin vascular nonvascular outcomes metaanalysis randomized controlled trials archives internal medicine 209–16 doi101001archinternmed2011628 pmid 22231610
algra rothwell 2012 effects regular aspirin longterm cancer incidence metastasis systematic comparison evidence observational studies versus randomised trials lancet oncology 518–27 doi101016s1470204512701122 pmid 22440112
bibbinsdomingo preventive services task force june 2016 aspirin primary prevention cardiovascular disease colorectal cancer preventive services task force recommendation statement annals internal medicine 836–45 doi107326m160577 pmid 27064677
sachs 2005 oral analgesics acute nonspecific pain american family physician 913–918 pmid 15768621 archived original 2014
gaciong 2003 real dimension analgesic activity aspirin thrombosis research 361–364 doi101016jthromres200308009 pmid 14592563
derry derry moore 2012 derry sheena caffeine analgesic adjuvant acute pain adults cochrane database systematic reviews cd009281 doi10100214651858cd009281pub2 pmid 22419343
blowfish aspirin caffeine tablet effervescent rally labs dailymed federal drug administration archived original february 2013 retrieved july 2012
hersh moore ross 2000 overthecounter analgesics antipyretics critical assessment clinical therapeutics 500–548 doi101016s0149291800800430 pmid 10868553
mett tfelthansen 2008 acute migraine therapy recent evidence randomized comparative trials current opinion neurology 331–337 doi101097wco0b013e3282fee843 pmid 18451718
kingery november 1997 critical review controlled clinical trials peripheral neuropathic pain complex regional pain syndromes pain 123–39 doi101016s0304395997000493 pmid 9415498
loder rizzoli january 2008 tensiontype headache clinical research 7635 88–92 doi101136bmj39412705868ad 2190284 pmid 18187725
gilmore michael february 2011 treatment acute migraine headache american family physician 271–80 pmid 21302868
bartfai conti march 2010 fever scientific world journal 490–503 doi101100tsw201050 2850202 pmid 20305990
pugliese beltramo torre october 2008 reyes reyeslike syndromes cell biochemistry function 741–6 doi101002cbf1465 pmid 18711704
beutler chesnut mattingly jamieson december 2009 fpins clinical inquiries aspirin children fever viral syndromes american family physician 1472 pmid 20000310
medications used treat fever american academy pediatrics archived original february 2013 retrieved november 2012
8180 united states federal register march 1986 archived original august 2011 retrieved november 2012
thea morris melanie stables adrian hobbs patricia souza paul colvillenash warner justine newson geoffrey bellingan derek gilroy august 2009 effects lowdose aspirin acute inflammatory responses humans journal immunology 2089–2096 doi104049jimmunol0900477 pmid 19597002 maint uses authors parameter link
myocardial infarction stsegment elevation acute management myocardial infarction stsegment elevation internet nice clinical guidelines asprin july 2013 pmid 25340241 archived original december 2015
quaas joshua november 2009 aspirin given immediately major heart attack stemi archived original august 2016 retrieved august 2016
newman david july 2011 aspirin prevent cardiovascular disease people known heart disease strokes archived original december 2015 retrieved november 2015
hall lorenc february 2010 secondary prevention coronary artery disease american family physician 289–96 pmid 20112887
baigent blackwell collins emberson godwin peto buring hennekens kearney meade patrono roncaglioni zanchetti 2009 aspirin primary secondary prevention vascular disease collaborative metaanalysis individual participant data randomised trials lancet 9678 1849–60 doi101016s0140673609605031 2715005 pmid 19482214
guirguisblake evans senger oconnor whitlock june 2016 aspirin primary prevention cardiovascular events systematic evidence review preventive services task force annals internal medicine systematic review metaanalysis 804–13 doi107326m152113 pmid 27064410
newman david january 2015 aspirin prevent first heart attack stroke thennt archived original december 2015 retrieved november 2015
wolff miller march 2009 aspirin primary prevention cardiovascular events update evidence preventive services task force annals internal medicine 405–10 doi10732600034819150620090317000009 pmid 19293073
preventive services task force aspirin prevention cardiovascular disease recommendation statement archived original september 2012 retrieved august 2012
berger lala krantz baker hiatt july 2011 aspirin prevention cardiovascular events patients without clinical cardiovascular disease metaanalysis randomized trials american heart journal 115–24e2 doi101016jahj201104006 pmid 21742097
norris september 2005 antiplatelet agents secondary prevention stroke perspective stroke journal cerebral circulation 2034–6 doi10116101str00001778871433946 pmid 16100022
sleight pouleur zannad july 2006 benefits challenges registerability polypill european heart journal 1651–6 doi101093eurheartjehi841 pmid 16603580
wang bhatt topol march 2006 aspirin clopidogrel resistance emerging clinical entity european heart journal 647–54 doi101093eurheartjehi684 pmid 16364973
oliveira silva silva lima september 2010 aspirin resistance fact fiction arquivos brasileiros cardiologia e91–4 doi101590s0066782x2010001300024 pmid 20944898
topçuoglu arsava february 2011 antiplatelet resistance stroke expert review neurotherapeutics 251–63 doi101586ern10203 3086673 pmid 21306212
bendor kleiman july 2009 assessment mechanisms clinical implication variability platelet response aspirin clopidogrel therapy american journal cardiology 227–33 doi101016jamjcard200903022 pmid 19576352
national guideline clearinghouse 2011 accfahascai guideline percutaneous coronary artery intervention report american college cardiology foundationamerican heart association task force practice guidelines society cardiovascular angiography interventions united states agency healthcare research quality ahrq archived original august 2012 retrieved august 2012
musumeci lorenzo valgimigli december 2011 dual antiplatelet therapy duration drivers current opinion cardiology suppl s4–14 doi10109701hco000040995911246ba pmid 22129582
cuzick thorat bosetti brown burn cook ford jacobs jankowski vecchia meyskens rothwell senn umar august 2014 estimates benefits harms prophylactic aspirin general population annals oncology 47–57 doi101093annoncmdu225 4269341 pmid 25096604
manzano pérezsegura april 2012 colorectal cancer chemoprevention future colorectal cancer prevention scientific world journal 2012 327341 doi1011002012327341 3353298 pmid 22649288
chan arber burn chia elwood hull logan rothwell schrör baron february 2012 aspirin chemoprevention colorectal neoplasia overview cancer prevention research philadelphia 164–78 doi10115819406207capr110391 3273592 pmid 22084361
thun jacobs patrono april 2012 role aspirin cancer prevention nature reviews clinical oncology 259–67 doi101038nrclinonc2011199 pmid 22473097
richman owens july 2017 aspirin primary prevention medical clinics north america review 71324 doi101016jmcna201703004 pmid 28577622
verdoodt friis dehlendorff albieri kjaer february 2016 nonsteroidal antiinflammatory drug risk endometrial cancer systematic review metaanalysis observational studies gynecologic oncology 352–8 doi101016jygyno201512009 pmid 26701413
bosetti rosato gallus cuzick vecchia april 2012 aspirin cancer risk quantitative review 2011 annals oncology 1403–1415 doi101093annoncmds113 pmid 22517822
sutcliffe connock gurung freeman johnson kandala grove gurung morrow clarke september 2013 aspirin prophylactic primary prevention cardiovascular disease cancer systematic review overview reviews health technology assessment winchester england 1–253 doi103310hta17430 4781046 pmid 24074752
2014 benefitrisk consideration longterm alternateday dose aspirin focus colorectal cancer prevention annals gastroenterology 87–88 3959543 pmid 24714632
preventive services task force march 2007 routine aspirin nonsteroidal antiinflammatory drugs primary prevention colorectal cancer preventive services task force recommendation statement annals internal medicine 361–4 doi10732600034819146520070306000008 pmid 17339621
bibbinsdomingo preventive services task force june 2016 aspirin primary prevention cardiovascular disease colorectal cancer preventive services task force recommendation statement annals internal medicine 836–45 doi107326m160577 pmid 27064677
national heart foundation australia rfrhd guideline development working group cardiac society australia zealand 2006 diagnosis management acute rheumatic fever rheumatic heart disease australia evidencebased review national heart foundation australia 33–37 archived original 20080726 retrieved 2011
working group pediatric acute rheumatic fever cardiology chapter indian academy pediatrics saxena kumar gera radhakrishnan mishra ahmed july 2008 consensus guidelines pediatric acute rheumatic fever rheumatic heart disease indian pediatrics 565–73 pmid 18695275
hashkes tauber somekh brik barash mukamel harel lorber berkovitch uziel pediatric rheumatlogy study group israel 2003 naproxen alternative aspirin treatment arthritis rheumatic fever randomized trial journal pediatrics 399–401 doi101067s0022347603003883 pmid 14517527
rowley shulman february 2010 pathogenesis management kawasaki disease expert review antiinfective therapy 197–203 doi101586eri09109 2845298 pmid 20109049
baumer love gupta haines maconochie october 2006 baumer harry salicylate treatment kawasaki disease children cochrane database systematic reviews cd004175 doi10100214651858cd004175pub2 pmid 17054199
duley hendersonsmart meher king 2007 duley lelia antiplatelet agents preventing preeclampsia complications cochrane database systematic reviews cd004659 doi10100214651858cd004659pub2 pmid 17443552
roberge villa nicolaides giguère vainio bakthi ebrashy bujold 2012 early administration lowdose aspirin prevention preterm term preeclampsia systematic review metaanalysis fetal diagnosis therapy 141–146 doi101159000336662 pmid 22441437
roberge nicolaides demers hyett chaillet bujold february 2017 role aspirin dose prevention preeclampsia fetal growth restriction systematic review metaanalysis american journal obstetrics gynecology 110–120e6 doi101016jajog201609076 pmid 27640943
dorsch lynch dunn rodgers schwartz colby montague smyth 2007 aspirin resistance patients stable coronary artery disease without history myocardial infarction annals pharmacotherapy 737–41 doi101345aph1h621 pmid 17456544
krasopoulos brister beattie buchanan 2008 aspirin resistance risk cardiovascular morbidity systematic review metaanalysis 7637 195–8 doi101136bmj39430529549be 2213873 pmid 18202034
pignatelli santo barillà gaudio violi 2008 multiple antiatherosclerotic treatments impair aspirin compliance effects aspirin resistance journal thrombosis haemostasis 1832–4 doi101111j15387836200803122x pmid 18680540
grosser tilo fries susanne lawson john kapoor shiv grant gregory fitzgerald garret 2013 drug resistance pseudoresistance unintended consequence enteric coating aspirin circulation published december 2012 377–85 doi101161circulationaha112117283 3552520 pmid 23212718 summary york times december 2012
invention safety digitaldukemedmcdukeedu archived original march 2016 retrieved september 2015
british national formulary british medical journal royal pharmaceutical society great britain 2003
aspirin monograph dosages medscapecom retrieved 2011
aspirin evidence dose needed medscape retrieved 2011
british national formulary children british medical journal royal pharmaceutical society 2006
aspirin information drugscom drugscom archived original 2008 retrieved 2008
oral aspirin information first databank archived original september 2000 retrieved 2008
raithel baenkler naegel buchwald schultis backhaus kimpel koch mach hahn konturek 2005 significance salicylate intolerance diseases lower gastrointestinal tract journal physiology pharmacology suppl 89–102 pmid 16247191 archived original april 2011
senna andri dama mezzelani andri 1995 tolerability imidazole salycilate aspirinsensitive patients allergy proc 251–4 doi102500108854195778702675 pmid 8566739
guide counter drugs archived original april 2008 retrieved april 2008
livingstone frank 1985 frequencies hemoglobin variants thalassemia glucose6phosphate dehydrogenase deficiency g6pd variants ovalocytosis human populations oxford university press isbn 0195036344
dengue dengue hemorrhagic fever information health care practitioners archived original march 2008 retrieved april 2008
macdonald 2002 aspirin banned 16year olds 7371 988c–988 doi101136bmj3257371988c 1169585 pmid 12411346
sørensen mellemkjaer blot nielsen gunnar lauge steffensen flemming hald mclaughlin joseph olsen jorgen 2000 risk upper gastrointestinal bleeding associated lowdose aspirin gastroenterol 2218–24 doi101111j15720241200002248x pmid 11007221
delaney opatrny brophy suissa 2007 drug–drug interactions antithrombotic medications risk gastrointestinal bleeding cmaj 347–51 doi101503cmaj070186 1942107 pmid 17698822
wallace 2008 prostaglandins nsaids gastric mucosal protection doesnt stomach digest physiological reviews 1547–1565 doi101152physrev000042008 pmid 18923189
fiorucci santucci wallace sardina romano soldato morelli 2003 interaction selective cyclooxygenase2 inhibitor aspirin noreleasing aspirin human gastric mucosa proceedings national academy sciences 10937–10941 bibcode2003pnas10010937f doi101073pnas1933204100 196906 pmid 12960371
general chemistry online acids bases buffer system buffered aspirin antoinefrostburgedu archived original april 2011 retrieved 2011
dammann saleki torz schulz krupp schürer timm gessner 2004 effects buffered plain acetylsalicylic acid formulations without ascorbic acid gastric mucosa healthy subjects alimentary pharmacology therapeutics 367–374 doi101111j13652036200401742x pmid 14984384
konturek kania hahn konturek 2006 ascorbic acid attenuates aspirininduced gastric damage role inducible nitric oxide synthase journal physiology pharmacology suppl 125–36 pmid 17218764
guitton caston ruel johnson pujol puel 2003 salicylate induces tinnitus activation cochlear nmda receptors journal neuroscience 3944–52 pmid 12736364 archived original december 2007
belay bresee holman khan shahriari schonberger 1999 reyes syndrome united states 1981 1997 england journal medicine 1377–82 doi101056nejm199905063401801 pmid 10228187
reyes syndrome choices national health service archived original august 2016 retrieved august 2016
stadelmann digenis tobin august 1998 impediments wound healing american journal surgery suppl 39s–47s pmid 9777971
maessenvisch roos 2014 dutch venous ulcer guideline update phlebology venous forum royal society medicine suppl 153–156 doi1011770268355514529693 pmid 24843102
bergesgimeno stevenson 2004 nonsteroidal antiinflammatory druginduced reactions desensitization journal asthma 375–84 doi101081jas120037650 pmid 15281324
vernooij haag lugt hofman krestin stricker breteler 2009 antithrombotic drugs presence cerebral microbleeds rotterdam scan study archives neurology 714–20 doi101001archneurol200942 pmid 19364926
gorelick 2009 cerebral microbleeds evidence heightened risk associated aspirin archives neurology 691–3 doi101001archneurol200985 pmid 19506128
whelton klag 1998 aspirin risk hemorrhagic stroke metaanalysis randomized controlled trials jama journal american medical association 1930–1935 doi101001jama280221930 pmid 9851479
saloheimo ahonen juvela pyhtinen savolainen hillbom january 2006 regular aspirinuse preceding onset primary intracerebral hemorrhage independent predictor death stroke 129–133 doi10116101str00001969910361831 pmid 16322483
medical knowledge selfassessment program students american college physicians clerkship directors internal medicine nephrology item
scher 1996 unplanned reoperation bleeding american surgeon 52–55 pmid 8540646
staff july 2015 strengthens warning heart attack stroke risk nonsteroidal antiinflammatory drugs archived original july 2015 retrieved july 2015
kreplick 2001 salicylate toxicity emergency medicine medscape archived original august 2012
gaudreault temple lovejoy 1982 relative severity acute versus chronic salicylate poisoning children clinical comparison pediatrics 566–9 pmid 7122154 primary source
marx john 2006 rosens emergency medicine concepts clinical practice mosbyelsevier 2242 isbn 9780323028455
morra bartle walker bowles reeves 1996 serum concentrations salicylic acid following topically applied salicylate derivatives annals pharmacotherapy 935–40 doi101177106002809603000903 pmid 8876850
baselt 2011 disposition toxic drugs chemicals seal beach california biomedical publications 20–23 isbn 0962652385
information healthcare professionals concomitant ibuprofen aspirin department health human services september 2006 archived original october 2010 retrieved november 2010
katzung basic clinical pharmacology mcgrawhill isbn 0838505651
watters wilson november 1973 effects aspirin metabolic availability ascorbic acid human beings journal clinical pharmacology 480–6 doi101002j155246041973tb00203x pmid 4490672 archived original march 2007
basu 1982 vitamin caspirin interactions internationale zeitschrift vitamin ernährungsforschung supplement international journal vitamin nutrition research 83–90 pmid 6811490
ioannides stone breacker basu 1982 impairment absorption ascorbic acid following ingestion aspirin guinea pigs biochemical pharmacology 4035–8 doi1010160006295282906529 pmid 6818974
reynolds 1982 aspirin similar analgesic antiinflammatory agents martindale extra pharmacopoeia 28th rittenhouse book distributors 234–82 isbn 0853691606
acetylsalicylic acid pocket guide chemical hazards national institute occupational safety health february 2015 archived original 2017
appendix 1989 contaminants update project exposure limits effect niosh pocket guide chemical hazards national institute occupational safety health february 2015 archived original june 2017
palleros daniel 2000 experimental organic chemistry york john wiley sons isbn 0471282502
barrans richard aspirin aging newton archived original 2008 retrieved 2008
carstensen attarchi 1985 decomposition aspirin solid state presence limited amounts moisture journal pharmaceutical sciences 318–21 doi101002jps2600770407 pmid 3379589
richard leroy myers august 2007 important chemical compounds reference guide abcclio isbn 9780313337581 archived original june 2013 retrieved november 2012
acetylsalicylic acid jinno laboratory school materials science toyohashi university technology march 1996 archived original january 2012 retrieved april 2014
vishweshwar mcmahon oliveira peterson zaworotko 2005 predictably elusive form aspirin journal american chemical society 16802–16803 doi101021ja056455b pmid 16316223
bond andrew boese roland desiraju gautam 2007 polymorphism aspirin crystalline aspirin intergrowths polymorphic domains angewandte chemie international edition 618–622 doi101002anie200603373 pmid 17139692
vane john robert 1971 inhibition prostaglandin synthesis mechanism action aspirinlike drugs nature biology 232–5 doi101038newbio231232a0 pmid 5284360
vane botting 2003 mechanism action aspirin thrombosis research 255–8 doi101016s0049384803003797 pmid 14592543 archived original february 2008
nobel prize physiology medicine 1982 nobelprizeorg archived original june 2017
aspirin heart attack stroke prevention american heart association archived original march 2008 retrieved 2008
tohgi konno tamura kimura kawano 1992 effects lowtohigh doses aspirin platelet aggregability metabolites thromboxane prostacyclin stroke 1400–1403 doi10116101str23101400 pmid 1412574
achhrish goel ruchi gupta anubhav goswami madhu soodan sharma yogesh sharma 2011 pharmacokinetic solubility dissolution profile nonsteroidal antiinflammatory drugs
martínezgonzález badimon 2007 mechanisms underlying cardiovascular effects coxinhibition benefits risks current pharmaceutical design 2215–27 doi102174138161207781368774 pmid 17691994
funk fitzgerald november 2007 cox2 inhibitors cardiovascular risk journal cardiovascular pharmacology 470–9 doi101097fjc0b013e318157f72d pmid 18030055
romano cianci simiele recchiuti 2015 lipoxins aspirintriggered lipoxins resolution inflammation european journal pharmacology 49–63 doi101016jejphar201503083 pmid 25895638
serhan chiang 2013 resolution phase lipid mediators inflammation agonists resolution current opinion pharmacology 632–40 doi101016jcoph201305012 3732499 pmid 23747022
weylandt 2015 docosapentaenoic acid derived metabolites mediators world lipid mediator medicine nutshell european journal pharmacology 108–115 doi101016jejphar201511002 pmid 26546723
somasundaram sigthorsson simpson watts jacob tavares rafi roseth foster 2000 uncoupling intestinal mitochondrial oxidative phosphorylation inhibition cyclooxygenase required development nsaidenteropathy alimentary pharmacology therapeutics 639–650 doi101046j13652036200000723x pmid 10792129
paulclark mark thong moradibidhendi niloufar cooper dianne gilroy derek 2004 15epilipoxin a4–mediated induction nitric oxide explains aspirin inhibits acute inflammation journal experimental medicine 69–78 doi101084jem20040566 2213311 pmid 15238606
mccarty block 2006 preadministration highdose salicylates suppressors nfkappab activation increase chemosensitivity many cancers example proapoptotic signal modulation therapy integrative cancer therapies 252–268 doi1011771534735406291499 pmid 16880431
hawley fullerton ross schertzer chevtzoff walker peggie zibrova green mustard kemp sakamoto steinberg hardie 2012 ancient drug salicylate directly activates ampactivated protein kinase science 6083 918–922 bibcode2012sci336918h doi101126science1215327 3399766 pmid 22517326
raffensperger lisa april 2012 clues aspirins anticancer effects revealed scientist 2862 doi101016s0262407912610732 archived original 2015
alfonso srivenugopal arumugam abbruscato weidanz bhat 2009 aspirin inhibits camptothecininduced p21cip1 levels potentiates apoptosis human breast cancer cells international journal oncology 597–608 doi103892ijo00000185 pmid 19212664
alfonso srivenugopal bhat 2009 aspirin acetylate multiple cellular proteins molecular medicine reports review 533–7 doi103892mmr00000132 pmid 21475861
ferguson boutros august 1970 death following selfpoisoning aspirin journal american medical association 1186–8 doi101001jama21371186 pmid 5468267
kaufman dubansky april 1970 darvon poisoning delayed salicylism case report pediatrics 610–1 pmid 5013423
levy tsuchiya august 1972 salicylate accumulation kinetics england journal medicine 430–2 doi101056nejm197208312870903 pmid 5044917
martin grootveld barry halliwell january 1988 23dihydroxybenzoic acid product human aspirin metabolism biochemical pharmacology 271–280 doi1010160006295288907290 pmid 3342084 maint uses authors parameter link
hartwig otto november 1983 pharmacokinetic considerations common analgesics antipyretics american journal medicine 30–7 doi1010160002934383902309 pmid 6606362
done november 1960 salicylate intoxication significance measurements salicylate blood cases acute ingestion pediatrics 800–7 pmid 13723722
chyka erdman christianson booze manoguerra caravati nelson olson cobaugh scharman woolf troutman 2007 salicylate poisoning evidencebased consensus guideline outofhospital management clinical toxicology american association poison control centers healthcare systems bureau health resources services administration department health human services 95–131 doi10108015563650600907140 pmid 17364628
prescott balalimood critchley johnstone proudfoot 1982 diuresis urinary alkalinisation salicylate poisoning british medical journal clinical research edition 6352 1383–6 doi101136bmj28563521383 1500395 pmid 6291695
dargan wallace jones 2002 evidenced based flowchart guide management acute salicylate aspirin overdose emergency medicine journal 206–9 doi101136emj193206 1725844 pmid 11971828
goldberg daniel summer 2009 aspirin turn century miracle drug chemical heritage foundation archived original november 2016
schiebinger october 2003 womens health clinical trials journal clinical investigation 973–7 doi101172jci19993 198535 pmid 14523031
regular aspirin intake acute myocardial infarction british medical journal 5905 440–3 march 1974 1633212 pmid 4816857
elwood cochrane burr sweetnam williams welsby hughes renton march 1974 randomized controlled trial acetyl salicylic acid secondary prevention mortality myocardial infarction british medical journal 5905 436–40 1633246 pmid 4593555
bayer united drug p512 sdny 1921 “disregarding however late autumn 1915 reclaim word already passed public domain consuming public learned know aspirin accepted name drug perhaps true extended course education might added proprietary meaning would difficult prove done months case plaintiff prove indifferent results selling consumer could protected well time consumers began directly 1915 nothing would easier insist tablet makers market drug small boxes bearing plaintiffs name take sale later instead allowed manufacturing chemists build part demand without regard trademark made must content hence appears nothing happening october 1915 march 1917 serve turn word trademark”
style manual committee huth edward 1994 scientific style format manual authors editors publishers cambridge university press isbn 9780521471541 archived original october 2015
aspirin versatile drug news 2009 archived original november 2016
cheng tsung 2007 history aspirin texas heart institute journal 392–393 1995051 pmid 17948100
sigma aldrich aspirin archived original august 2011 retrieved july 2009
british pharmacopoeia index 2009 archived original april 2009 retrieved july 2009
cambridge lees hooke russell 1991 antithrombotic actions aspirin horse equine veterinary journal 123–7 doi101111j204233061991tb02736x pmid 1904347
lappin michael 2001 feline internal medicine secrets philadelphia hanley belfus isbn 1560534613
analgesics toxicity merck archived original april 2015 retrieved march 2016
plants poisonous livestock cornell university department animal science archived original august 2015 retrieved march 2016



notes

jeffreys diarmuid august 2005 aspirin remarkable story wonder drug bloomsbury isbn 1582346003
sheldon peter 2007 fall rise aspirin wonder drug brewin books isbn 9781858584034

external linksedit


pharmacy pharmacology portal





wikimedia commons media related aspirin



aspirin curlie based dmoz
national library medicine drug information portal aspirin
niosh pocket guide chemical hazards acetyl salicylic acid
take aspirin uses dangers still discovered aspirin enters century shauna roberts american chemical society
ling greg 2005 aspirin products made thomson gale












antithrombotics thrombolytics anticoagulants antiplatelet drugs



antiplatelet drugs




glycoprotein iibiiia inhibitors



abciximab
eptifibatide
orbofiban
roxifiban
sibrafiban§
tirofiban





receptorp2y12 inhibitors



thienopyridines

clopidogrel
prasugrel
ticlopidine


nucleotidenucleoside analogs

cangrelor
elinogrel
ticagrelor







prostaglandin analogue pgi2



beraprost
iloprost
prostacyclin
treprostinil





inhibitors



acetylsalicylic acidaspirin
aloxiprin
carbasalate calcium
indobufen
triflusal





thromboxane inhibitors



thromboxane synthase inhibitors

dipyridamole aspirin
picotamide
terbogrel


receptor antagonists

terbogrel
terutroban§







phosphodiesterase inhibitors



cilostazol
dipyridamole
triflusal









cloricromen
ditazole
vorapaxar








anticoagulants




vitamin antagonists
inhibit



coumarins acenocoumarol
coumatetralyl
dicoumarol
ethyl biscoumacetate
phenprocoumon
warfarin
13indandiones clorindione
diphenadione
phenindione
tioclomarol





factor inhibitors
inhibition




heparin group
glycosaminoglycans
bind antithrombin



molecular weight heparin

bemiparin
certoparin
dalteparin
enoxaparin
nadroparin
parnaparin
reviparin
tinzaparin‡


oligosaccharides

fondaparinux
idraparinux§


heparinoids

danaparoid
dermatan sulfate
sulodexide







direct inhibitors xabans



apixaban
betrixaban
darexaban§
edoxaban
otamixaban§
rivaroxaban








direct thrombin inhibitors



bivalent hirudin

bivalirudin
desirudin
lepirudin


univalent argatroban
dabigatran
efegatran
inogatran§
melagatran‡
ximelagatran‡









antithrombin
defibrotide
protein

drotrecogin alfa‡


ramatroban
reg1








thrombolytic drugs
fibrinolytics



plasminogen activators rtpa

alteplase
reteplase
tenecteplase




saruplase
urokinase


anistreplase
monteplase
streptokinase
serine endopeptidases ancrod
brinase
fibrinolysin





nonmedicinal



citrate
edta
oxalate









whoem
‡withdrawn market
clinical trials

†phase
§never phase




















nonsteroidal antiinflammatory drugs nsaids primarily m01a m02a also n02ba



pyrazolones
pyrazolidines



aminophenazone
ampyrone
azapropazone
clofezone
difenamizole
famprofazone
feprazone
kebuzone
metamizole
mofebutazone
morazone
nifenazone
oxyphenbutazone
phenazone
phenylbutazone
propyphenazone
sulfinpyrazone
suxibuzone‡





salicylates



aspirin acetylsalicylic acid
aloxiprin
benorylate
carbasalate calcium
diflunisal
dipyrocetyl
ethenzamide
guacetisal
magnesium salicylate
methyl salicylate
salsalate
salicin
salicylamide
salicylic acid salicylate
sodium salicylate





acetic acid derivatives
related substances



aceclofenac
acemetacin
alclofenac
amfenac
bendazac
bromfenac
bumadizone
bufexamac
diclofenac
difenpiramide
etodolac
felbinac
fenclozic acid
fentiazac
indometacin
indometacin farnesil
isoxepac
ketorolac
lonazolac
oxametacin
prodolic acid
proglumetacin
sulindac
tiopinac
tolmetin
zomepirac†





oxicams



ampiroxicam
droxicam
isoxicam
lornoxicam
meloxicam
piroxicam
tenoxicam





propionic acid derivatives
profens



alminoprofen
benoxaprofen†
carprofen‡
dexibuprofen
dexketoprofen
fenbufen
fenoprofen
flunoxaprofen
flurbiprofen
ibuprofen
ibuproxam
indoprofen†
ketoprofen
loxoprofen
miroprofen
naproxen
oxaprozin
pirprofen
suprofen
tarenflurbil
tepoxalin‡
tiaprofenic acid
vedaprofen‡
coxinhibiting nitric oxide donator naproxcinod





narylanthranilic acids
fenamates



azapropazone
clonixin
etofenamate
flufenamic acid
flunixin
meclofenamic acid
mefenamic acid
morniflumate
niflumic acid
tolfenamic acid
flutiazin





coxibs



apricoxib
celecoxib
cimicoxib‡
deracoxib‡
etoricoxib
firocoxib‡
lumiracoxib†
mavacoxib‡
parecoxib
robenacoxib‡
rofecoxib†
valdecoxib†









aminopropionitrile
benzydamine
chondroitin sulfate
diacerein
fluproquazone
glucosamine
glycosaminoglycan
hyperforin
nabumetone
nimesulide
oxaceprol
proquazone
superoxide dismutaseorgotein
tenidap






items listed bold indicate initially developed compounds specific groups whoem †withdrawn drugs ‡veterinary medications















analgesics n02a n02b



opioids




opiatesopium



codeine paracetamol aspirin
morphine naltrexone
opium
laudanum
paregoric





semisynthetic



acetyldihydrocodeine
benzylmorphine
buprenorphine naloxone
desomorphine
diamorphine heroin
dihydrocodeine paracetamol
dihydromorphine
ethylmorphine
hydrocodone paracetamol ibuprofen aspirin
hydromorphinol
hydromorphone
nicocodeine
nicodicodeine
nicomorphine
oxycodone paracetamol aspirin ibuprofen naloxone naltrexone
oxymorphone
thebacon





synthetic



alfentanil
alphaprodine
anileridine
butorphanol
carfentanil
dextromoramide
dextropropoxyphene
dezocine
fentanyl fluanisone
ketobemidone
levorphanol
lofentanil
meptazinol
methadone
nalbuphine
nfepp
pentazocine
pethidine meperidine
phenadoxone
phenazocine
piminodine
piritramide
propiram
remifentanil
sufentanil
tapentadol
tilidine
tramadol








paracetamoltype



acetanilide‡
bucetin‡
butacetin‡
paracetamol acetaminophen
parapropamol‡
phenacetin‡
propacetamol‡





nsaids




propionates



fenoprofen
flurbiprofen
ibuprofen
ketoprofen
naproxen
oxaprozin





oxicams



meloxicam
piroxicam





acetates



diclofenac
indometacin
ketorolac
nabumetone
sulindac
tolmetin





cox2 inhibitors



celecoxib
etoricoxib
lumiracoxib
parecoxib
rofecoxib
valdecoxib





fenamates



meclofenamic acid
mefenamic acid





salicylates



aspirin acetylsalicylic acid paracetamolcaffeine
benorylate
diflunisal
ethenzamide
magnesium salicylate
salicin
salicylamide
salsalate
wintergreen methyl salicylate





pyrazolones



aminophenazone‡
ampyrone
metamizole dipyrone
nifenazone
phenazone
propyphenazone paracetamolcaffeine





others



glafenine








cannabinoids



cannabidiol
cannabis
nabilone
nabiximols
tetrahydrocannabinol dronabinol





channel
modulators




calcium blockers



gabapentin
gabapentin enacarbil
pregabalin
ziconotide





sodium blockers



carbamazepine
lacosamide
local anesthetics cocaine lidocaine
mexiletine
nefopam
tricyclic antidepressants amitriptyline


nav1718selective dsp2230§
funapide§
pf05089771§
raxatrigine§





potassium openers



flupirtine








myorelaxants



carisoprodol
chlorzoxazone
cyclobenzaprine
mephenoxalone
methocarbamol
orphenadrine





others



analgesic adjuvant
analgecine
camphor
capsaicin
clonidine
ketamine
menthol
methoxyflurane
nefopam
proglumide
tricyclic antidepressants amitriptyline









whoem
‡withdrawn market
clinical trials

†phase
§never phase




















acnetreating agents



antibacterial



azelaic acid
benzoyl peroxide
8hydroxyquinoline
blue light therapy
tree





keratolytic



glycolic acid
salicylic acid
sulfur
benzoyl peroxide





antiinflammatory



nicotinamide
ibuprofen
aspirin
light therapy





antibiotics



clindamycin
dapsone
erythromycin
sulfacetamide
tetracyclines lymecycline
minocycline
doxycycline





hormonal



antiandrogens

bicalutamide
cyproterone acetate
drospirenone
flutamide
spironolactone


estrogens

estradiol
ethinylestradiol







retinoids



adapalene
isotretinoin
motretinide
tazarotene
tretinoin









benzamycin
epristeride
mesulfen
pelretin
stridex
tioxolone





combinations



adapalenebenzoyl peroxide
benzoyl peroxideclindamycin
clindamycintretinoin
erythromycinisotretinoin
sulfacetamidesulfur









whoem
‡withdrawn market
clinical trials

†phase
§never phase




















salicylates






salicylic acid
aspirin
aloxiprin
methyl salicylate
magnesium salicylate
ethyl salicylate
bismuth subsalicylate
sodium salicylate
salicylamide
salicin
benorilate
salsalate
ethenzamide
diflunisal
trolamine salicylate
homosalate
salicylmethylecgonine
octyl salicylate
aluminon
benzyl salicylate
copper aspirinate
potassium salicylate

















prostanoid signaling modulators



receptor
ligands













agonists prostaglandin
treprostinil


antagonists asapiprant
laropiprant
vidupiprant









agonists indometacin
prostaglandin


antagonists adc3680
azd1981
u3405
fevipiprant
mk1029
mk7246
qav680
ramatroban
setipiprant
timapiprant
tm30089
vidupiprant

















agonists beraprost
enprostil
iloprost ciloprost
latanoprost
lubiprostone
misoprostol
prostaglandin alprostadil
prostaglandin dinoprostone
sulprostone


antagonists ah6809
ono8130
sc19220
sc51089
sc51322









agonists butaprost
misoprostol
prostaglandin alprostadil
prostaglandin dinoprostone
treprostinil


antagonists ah6809
pf04418948
4155









agonists beraprost
carbacyclin
cicaprost
enprostil
iloprost ciloprost
isocarbacyclin
latanoprost
misoprostol
prostaglandin
prostaglandin alprostadil
prostaglandin dinoprostone
remiprostol
sulprostone


antagonists l798106









agonists lubiprostone
misoprostol
prostaglandin alprostadil
prostaglandin dinoprostone
tcs2510


antagonists grapiprant
gw627368
l161982
onoae3208





unsorted



agonists 1616dimethyl prostaglandin
aganepag
carboprost
evatanepag
gemeprost
nocloprost
omidenepag
prostaglandin dinoprost
simenepag
taprenepag












agonists alfaprostol
bimatoprost
carboprost
cloprostenol
enprostil
fluprostenol
latanoprost
prostaglandin
prostaglandin dinoprost
sulotroban
tafluprost
travoprost
unoprostone









agonists act333679
afp07
beraprost
bmy45778
carbacyclin
cicaprost
iloprost ciloprost
isocarbacyclin
mre269
ns304
prostacyclin prostaglandin epoprostenol
prostaglandin alprostadil
ralinepag
selexipag
taprostene
tra418
treprostinil


antagonists ro1138452





txa2



agonists carbocyclic thromboxane
ibop
thromboxane
u46619
vapiprost


antagonists 12hete
13apa
aa2414
argatroban
u3405
bms180291
daltroban
domitroban
ep045
gr32191
ici185282
ici192605
ifetroban
imitrodast
l655240
l670596
linotroban
mipitroban
ono3708
ono11120
picotamide
pinane thromboxane
ramatroban
ridogrel
s145
samixogrel
seratrodast
sq28668
sq29548
sulotroban
terbogrel
terutroban
tra418





unsorted



arbaprostil
ataprost
ciprostene
clinprost
cobiprostone
delprostenate
deprostil
dimoxaprost
doxaprost
ecraprost
eganoprost
enisoprost
eptaloprost
esuberaprost
etiproston
fenprostalene
flunoprost
froxiprost
lanproston
limaprost
luprostiol
meteneprost
mexiprostil
naxaprostene
nileprost
nocloprost
ornoprostil
oxoprostol
penprostene
pimilprost
piriprost
posaraprost
prostalene
rioprostil
rivenprost
rosaprostol
spiriprostil
tiaprost
tilsuprost
tiprostanide
trimoprostil
viprostol








enzyme
inhibitors





ptgs



salicylic acids aloxiprin
aspirin acetylsalicylic acid
benorilate benorylate
carbasalate calcium
diflusinal
dipyrocetyl
ethenzamide
guacetisal
magnesium salicylate
mesalazine 5aminosalicylic acid
methyl salicylate
salacetamide
salicin
salicylamide
salicylate salicylic acid
salsalate
sodium salicylate
triflusal acetic acids aceclofenac
acemetacin
aclofenac
amfenac
alclofenac
bendazac
bromfenac
bufexamac
bumadizone
cinmetacin
clometacin
diclofenac
difenpiramide
etodolac
felbinac
fenclofenac
fentiazac
glucametacin
indometacin indomethacin
indometacin farnesil
ketorolac
lonazolac
mofezolac
nabumetone
oxametacin
oxindanac
proglumetacin
sulindac
sulindac sulfide
tolmetin
zidometacin
zomepirac propionic acids alminoprofen
benoxaprofen
bucloxic acid blucloxate
butibufen
carprofen
dexibuprofen
dexindoprofen
dexketoprofen
fenbufen
fenoprofen
flunoxaprofen
flurbiprofen
ibuprofen
ibuproxam
indoprofen
ketoprofen
loxoprofen
miroprofen
naproxen
naproxcinod
oxaprozin
pirprofen
pranoprofen
suprofen
tarenflurbil
tepoxalin
tiaprofenic acid tiaprofenate
vedaprofen anthranilic acids fenamic acids etofenamic acid etofenamate
floctafenic acid floctafenate
flufenamic acid flufenamate
meclofenamic acid meclofenamate
mefenamic acid mefenamate
morniflumic acid morniflumate
niflumic acid niflumate
talinflumic acid talinflumate
tolfenamic acid tolfenamate pyrazolones azapropazone
dipyrone
isopyrin
oxyphenbutazone
phenylbutazone enolic acids oxicams ampiroxicam
droxicam
enolicam
isoxicam
lornoxicam
meloxicam
piroxicam
tenoxicam 4aminoquinolines antrafenine
floctafenine
glafenine quinazolines fluproquazone
proquazone aminonicotinic acids clonixeril
clonixin
flunixin sulfonanilides flosulide
nimesulide aminophenols anilines acetanilide
am404 narachidonoylaminophenol
bucetin
paracetamol acetaminophen
parapropamol
phenacetin
propacetamol selective cox2 inhibitors coxibs apricoxib
celecoxib
cimicoxib
deracoxib
etoricoxib
firocoxib
lumiracoxib
mavacoxib
parecoxib
polmacoxib
robenacoxib
rofecoxib
tilmacoxib
valdecoxib othersunsorted anitrazafen
clobuzarit
curcumin
dup697
fk3311
flumizole
fr122047
glimepiride
hyperforin
itazigrel
l655240
l670596
licofelone
menatetrenone vitamin
ncx466
ncx4040
ns398
pamicogrel
resveratrol
romazarit
rosmarinic acid
rutecarpine
satigrel
sc236
sc560
sc58125
tenidap
tiflamizole
timegadine
trifenagrel
tropesin





pgd2s



retinoids
selenium selenium tetrachloride sodium selenite selenium disulfide





pges

hql79



pgfs

bimatoprost



pgi2s

tranylcypromine



txas



camonagrel
dazmegrel
dazoxiben
furegrelate
isbogrel
midazogrel
nafagrel
nicogrelate
ozagrel
picotamide
pirmagrel
ridogrel
rolafagrel
samixogrel
terbogrel
u63557a








others



precursors linoleic acid
γlinolenic acid gamolenic acid
dihomoγlinolenic acid
diacylglycerol
arachidonic acid
prostaglandin
prostaglandin








also
receptorsignaling modulators
leukotriene signaling modulators
nuclear receptor modulators









authority control



40003516
00577498











retrieved httpsenwikipediaorgwindexphptitleaspirinoldid818552007 categories aspirinacetate estersantiplatelet drugsbayer agbrands became genericequine medicationsgerman inventionshepatotoxinsnonsteroidal antiinflammatory drugssalicylatesworld health organization essential medicinescovalent inhibitorschemical substances emergency medicinephenol esters1897 sciencehidden categories maint uses authors parameteruse dates january 2013good articlesinfobox drug local varianttemplatedrugscom link nonstandard subpageecha infocard wikidatainfobox drug articles nondefault infobox titledrugboxes contain changes watched fieldsall pages needing factual verificationwikipedia articles needing factual verification august 2016all articles contain original researcharticles contain original research march 2011all articles lacking reliable referencesarticles lacking reliable references august 2016all articles unsourced statementsarticles unsourced statements september 2015articles unsourced statements february 2017articles dmoz linkswikipedia articles identifiersrtt
